VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
IOSP
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
IOSPInnospec Inc.
$81.66$2.0B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders

IOSP logoInnospec Inc.(IOSP)Earnings, Financials & Key Ratios

IOSP•NASDAQ
$81.66
17.5× P/E·Price updated Jul 7, 2026
SectorBasic MaterialsIndustrySpecialty ChemicalsSub-IndustrySpecialty additives and formulation chemicals
AboutInnospec Inc. develops, manufactures, blends, markets, and supplies specialty chemicals in the United States, rest of North America, the United Kingdom, rest of Europe, and internationally. The company's Fuel Specialties segment offers a range of specialty chemical products that are used as additives in various fuels. This segment's products are used in the operation of automotive, marine, and aviation engines; power station generators; and heating oil. Its Performance Chemicals segment provides technology-based solutions for its customers' processes or products that focuses on the personal care, home care, agrochemical, and metal extraction markets. The company's Oilfield Services segment develops and markets chemical solutions for fracturing, stimulation, and completion operations; and products for oil and gas production, as well as products to prevent loss of mud in drilling operations. It sells its products primarily to oil and gas exploration and production companies, oil refineries, fuel manufacturers and users, personal care and home care companies, formulators of agrochemical and metal extraction formulations, and other chemical and industrial companies. The company was formerly known as Octel Corp. and changed its name to Innospec Inc. in January 2006. Innospec Inc. was founded in 1938 and is headquartered in Englewood, Colorado.Show more
  • Revenue$1.78B-3.7%
  • EBITDA$206M-7.1%
  • Net Income$117M+227.5%
  • EPS (Diluted)4.67+228.9%
  • Gross Margin27.69%-5.9%
  • EBITDA Margin11.56%-3.6%
  • Operating Margin8.79%-8.8%
  • Net Margin6.56%+239.9%
  • ROE9.15%+204.0%

IOSP Price & Volume

Innospec Inc. (IOSP) stock price & volume — 10-year historical chart

Loading chart...

Cyclical Margin Compression Challenges Innospec Financial Resilience

Investment Thesis • Updated 2026Q1

VerdictNeutral
Growth:Mixed
Profitability:Moderate
Financial:Fortress
Cash Flow:Mixed
Primary Risk:Cyclical End-Market Exposure

Key Thesis Takeaways

  • Innospec maintains a fortress balance sheet with a 0.04 debt-to-equity ratio, yet the company faces persistent headwinds from volatile specialty chemical demand and inconsistent earnings quality.
  • While the firm's liquidity position remains robust with $289.1 million in cash, investors should monitor the ongoing gross margin contraction, which fell from 31.5% in 2023Q4 to 27.3% in 2026Q1.
  • Future performance appears contingent on the company's ability to offset rising input costs and manage legacy environmental liabilities that periodically obscure underlying profitability.

Verdict Logic

while the firm's 0.04 debt-to-equity ratio provides a significant safety buffer, the current 17.69 P/E ratio and inconsistent free cash flow margins suggest that investors should wait for more stable earnings growth before committing capital.

IOSP Growth Metrics

Innospec Inc. (IOSP) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR

Revenue CAGR

10 Years5.79%
5 Years8.31%
3 Years-3.26%
TTM0.25%

Profit CAGR

10 Years-0.25%
5 Years32.36%
3 Years-4.29%
TTM322.96%

EPS CAGR

10 Years-0.4%
5 Years32.12%
3 Years-4.25%
TTM333.02%

Return on Capital

10 Years11.43%
5 Years12.69%
3 Years12.32%
Last Year11.02%

IOSP Recent Earnings

Innospec Inc. (IOSP) EPS & revenue vs analyst estimates — last 4 quarters

Full history →
●Beat EPS 10/12 qtrs (83%)●Beat Revenue 3/12 qtrs (25%)
Q2 2026Latest
May 7, 2026
Metric
Actual
Est
EPS
$1.05+2.9%
$1.02
Rev
$453M+4.9%
$432M
Q1 2026
Feb 17, 2026
Metric
Actual
Est
EPS
$1.50+19.0%
$1.26
Rev
$456M-1.1%
$461M
Q4 2025
Nov 4, 2025
Metric
Actual
Est
EPS
$1.12+8.7%
$1.03
Rev
$442M-4.1%
$461M
Q3 2025
Aug 5, 2025
Metric
Actual
Est
EPS
$1.26+7.7%
$1.17
Rev
$440M-2.3%
$450M
QuarterDateEPS (Act vs Est)Revenue (Act vs Est)
Q2 2026LatestMay 7, 2026
$1.05vs $1.02+2.9%
$453Mvs $432M+4.9%
Q1 2026Feb 17, 2026
$1.50vs $1.26+19.0%
$456Mvs $461M-1.1%
Q4 2025Nov 4, 2025
$1.12vs $1.03+8.7%
$442Mvs $461M-4.1%
Q3 2025Aug 5, 2025
$1.26vs $1.17+7.7%
$440Mvs $450M-2.3%
Based on last 12 quarters of dataView full earnings history →

Latest IOSP News

Recent stock market news and headlines for Innospec Inc. (IOSP)

GlobeNewsWire·1 day ago
Innospec Schedules Second Quarter 2026 Earnings Release and Conference Call

ENGLEWOOD, Colo., July 06, 2026 (GLOBE NEWSWIRE) -- Innospec Inc. (NASDAQ: IOSP) today announced that it will release second quarter 2026 earnings results on Tuesday, August 4, 2026 after market close. Following the release of its results, Patrick S. Williams, President and Chief Executive Officer, and Ian Cleminson, Executive Vice President and Chief Financial Officer, will host an interactive conference call on Wednesday, August 5, 2026, at 10:00 a.m. ET.

Zacks Investment Research·5 days ago
EMN or IOSP: Which Is the Better Value Stock Right Now?

Investors looking for stocks in the Chemical - Diversified sector might want to consider either Eastman Chemical (EMN) or Innospec (IOSP). But which of these two stocks presents investors with the better value opportunity right now?

Globe News Wire·Jun 30, 2026
Innospec Publishes 2025 Sustainability Report Highlighting Measurable Progress and Responsible Growth

ENGLEWOOD, Colo. , June 30, 2026 (GLOBE NEWSWIRE) -- Innospec Inc. (NASDAQ: IOSP), a global specialty chemicals company, has published its 2025 Sustainability Report, highlighting measurable progress across environmental performance, safety, innovation, and responsible business practices, while maintaining disciplined execution and strong cash generation.

GlobeNewsWire·Jun 30, 2026
Innospec Publishes 2025 Sustainability Report Highlighting Measurable Progress and Responsible Growth

ENGLEWOOD, Colo., June 30, 2026 (GLOBE NEWSWIRE) -- Innospec Inc. (NASDAQ: IOSP), a global specialty chemicals company, has published its 2025 Sustainability Report, highlighting measurable progress across environmental performance, safety, innovation, and responsible business practices, while maintaining disciplined execution and strong cash generation.

Peers Comparison

Key metrics vs top competitors for Innospec Inc. (IOSP)

Full Screener →
CompanyPriceMarket CapP/E RatioRev Growth (1Y)Net MarginROEDiv Yield
IOSP logoIOSPInnospec Inc.Current
$81.66$2.01B17.49-3.65%6.56%9.15%2.08%
HWKN logoHWKNHawkins, Inc.
$136.26$2.84B34.8511.21%7.52%15.96%—
BCPC logoBCPCBalchem Corporation
$168.11$5.38B35.398.75%14.95%12.38%—
ITIC logoITICInvestors Title Company
$276.75$522.5M14.905.6%13.59%14.03%—
KWR logoKWRQuaker Chemical Corporation
$153.41$2.66B-1095.792.66%0.22%0.31%—
CBT logoCBTCabot Corporation
$87.41$4.56B14.52-7.04%7.97%16.75%—

Compare IOSP vs Peers

Innospec Inc. (IOSP) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs HWKN

Most directly comparable listed peer for IOSP.

Scale Benchmark

vs XOM

Larger-name benchmark to compare IOSP against a more recognizable public peer.

Peer Set

Compare Top 5

vs HWKN, BCPC, ITIC, KWR

IOSP SEC Filings & Documents

Innospec Inc. (IOSP) SEC filings — annual & quarterly reports (10-K, 10-Q)

8-K Announcements

6
Material company update

May 13, 2026·SEC

Material company update

May 8, 2026·SEC

Material company update

Feb 18, 2026·SEC

10-K Annual Reports

4
FY 2026

Feb 18, 2026·SEC

FY 2025

Feb 19, 2025·SEC

FY 2024

Feb 14, 2024·SEC

10-Q Quarterly Reports

6
FY 2026

May 8, 2026·SEC

FY 2025

Nov 5, 2025·SEC

FY 2025

Aug 6, 2025·SEC

Get notified when IOSP posts new earnings or crosses analyst targets

Free. No account needed. Unsubscribe any time.

Free. Unsubscribe any time.

IOSP Frequently Asked Questions

Innospec Inc. (IOSP) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials
What is Innospec Inc.'s revenue?

Innospec Inc. (IOSP) reported $1.79B in revenue for fiscal year 2025. This represents a 285% increase from $465.0M in 1998.

How fast is Innospec Inc. growing?

Innospec Inc. (IOSP) saw revenue decline by 3.7% over the past year.

Is IOSP profitable?

Yes, Innospec Inc. (IOSP) is profitable, generating $114.2M in net income for fiscal year 2025 (6.6% net margin).

Dividend & Returns
Does IOSP pay dividends?

Yes, Innospec Inc. (IOSP) pays a dividend with a yield of 2.08%. This makes it attractive for income-focused investors.

What is IOSP's return on equity?

Innospec Inc. (IOSP) has a return on equity (ROE) of 9.1%. This is below average, suggesting room for improvement.

What is Innospec Inc.'s free cash flow?

Innospec Inc. (IOSP) generated $76.8M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.

What if you invested $1,000 in IOSP back in 1998?

Total return calculator · dividends reinvested · 28+ years of data

See returns →